Cabaletta Bio (CABA) Total Liabilities (2018 - 2025)

Cabaletta Bio has reported Total Liabilities for 8 years, with the latest figure at $53.0 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 62.12% year-over-year to $53.0 million; the trailing twelve-month figure through Dec 2025 stood at $53.0 million (up 62.12% YoY), and the FY2025 full-year result was $53.0 million, up 62.12% from the prior year.
• Total Liabilities for Q4 2025 stood at $53.0 million, up from $50.3 million in the prior quarter.
• The five-year high for Total Liabilities was $53.0 million in Q4 2025, with the low at $4.0 million in Q1 2021.
• Average Total Liabilities over 5 years is $20.0 million, with a median of $12.4 million recorded in 2022.
• Year-over-year, Total Liabilities retreated 3.69% in 2022 and surged 157.1% in 2025.
• Tracing CABA's Total Liabilities over 5 years: stood at $8.4 million in 2021, then jumped by 48.54% to $12.4 million in 2022, then soared by 40.2% to $17.5 million in 2023, then surged by 87.43% to $32.7 million in 2024, then soared by 62.12% to $53.0 million in 2025.
• The last three Total Liabilities figures came in at $53.0 million (Q4 2025), $50.3 million (Q3 2025), and $46.0 million (Q2 2025), per Business Quant data.

Peer Comparison